Authors:
ALFIAR F
PRINCE HM
IMRIE K
STEWART AK
CRUMP M
KEATING A
Citation: F. Alfiar et al., BONE-MARROW MONONUCLEAR CELL COUNT DOES NOT PREDICT NEUTROPHIL AND PLATELET RECOVERY FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANT - VALUE OFTHE COLONY-FORMING UNIT GRANULOCYTE-MACROPHAGE (CFU-GM) ASSAY, Cell transplantation, 6(5), 1997, pp. 491-495
Authors:
CRUMP M
YEE K
IMRIE K
COUBAN S
STEWART AK
SARAGOSA R
KEATING A
Citation: M. Crump et al., PLATELET RECOVERY AFTER HIGH-DOSE (HD) CHEMOTHERAPY (C) IS SUPERIOR WITH PERIPHERAL-BLOOD STEM-CELLS (PBSC) MOBILIZED BY C-CSF COMPARED TO G-CSF ALONE(G), European journal of cancer, 33, 1997, pp. 397-397
Authors:
CRUMP M
ALHOMAIDHI A
IMRIE K
STEWART AK
BRANDWEIN J
KEATING A
Citation: M. Crump et al., LOW INCIDENCE OF MYELODYSPLASIA (MDS) OR ACUTE-LEUKEMIA (AML) AFTER AUTOLOGOUS BLOOD OR MARROW TRANSPLANT WITHOUT TOTAL-BODY RADIATION (TBI) FOR LYMPHOMA, European journal of cancer, 33, 1997, pp. 406-406
Authors:
GIROUARD C
DUFRESNE J
IMRIE K
STEWART AK
BRANDWEIN J
PRINCE HM
PANTOLONY D
KEATING A
CRUMP M
Citation: C. Girouard et al., SALVAGE CHEMOTHERAPY WITH MINI-BEAM FOR RELAPSED OR REFRACTORY NON-HODGKINS-LYMPHOMA PRIOR TO AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Annals of oncology, 8(7), 1997, pp. 675-680
Authors:
ALHOMAIDHI A
CRUMP M
IMRIE K
STEWART AK
BRANDWEIN J
SQUIRE J
KEATING A
Citation: A. Alhomaidhi et al., LOW INCIDENCE OF MYELODYSPLASIA OR ACUTE-LEUKEMIA AFTER AUTOLOGOUS BLOOD AND MARROW TRANSPLANT WITHOUT TOTAL-BODY RADIATION FOR LYMPHOMA, Experimental hematology, 25(8), 1997, pp. 316-316
Authors:
IMRIE K
STEWART AK
CRUMP RM
PRINCE HM
TRIP K
KEATING A
Citation: K. Imrie et al., BLOOD STEM-CELL COLLECTION - FACTORS INFLUENCING THE RECOVERY OF GRANULOCYTE-MACROPHAGE COLONY-FORMING CELLS, Cell transplantation, 5(3), 1996, pp. 379-383
Authors:
PRINCE HM
CRUMP M
IMRIE K
STEWART AK
GIROUARD C
BRANDWEIN JM
CARSTAIRS K
PANTALONY D
SCOTT G
SUTCLIFFE S
SUTTON DMC
TSANG R
KEATING A
Citation: Hm. Prince et al., INTENSIVE THERAPY AND AUTOTRANSPLANT FOR PATIENTS WITH AN INCOMPLETE RESPONSE TO FRONT-LINE THERAPY FOR LYMPHOMA, Annals of oncology, 7(10), 1996, pp. 1043-1049
Authors:
PRINCE HM
IMRIE K
SUTHERLAND DR
KEATING A
MEHARCHAND J
CRUMP RM
GIROUARD C
TRIP K
STEWART AK
Citation: Hm. Prince et al., PERIPHERAL-BLOOD PROGENITOR-CELL COLLECTIONS IN MULTIPLE-MYELOMA - PREDICTORS AND MANAGEMENT OF INADEQUATE COLLECTIONS, British Journal of Haematology, 93(1), 1996, pp. 142-145
Authors:
PRINCE HM
IMRIE K
CRUMP M
STEWART AK
GIROUARD C
COLWILL R
BRANDWEIN J
TSANG RW
SCOTT JG
SUTTON DMC
PANTALONY D
CARSTAIRS K
SUTCLIFFE SB
KEATING A
Citation: Hm. Prince et al., THE ROLE OF INTENSIVE THERAPY AND AUTOLOGOUS BLOOD AND MARROW TRANSPLANTATION FOR CHEMOTHERAPY-SENSITIVE RELAPSED AND PRIMARY REFRACTORY NON-HODGKINS-LYMPHOMA - IDENTIFICATION OF MAJOR PROGNOSTIC GROUPS, British Journal of Haematology, 92(4), 1996, pp. 880-889
Authors:
BUCKSTEIN R
CRUMP M
IMRIE K
SUTTON D
PANTALONY D
SHER G
STEWART AK
KEATING A
Citation: R. Buckstein et al., CYTOGENETIC ABNORMALITIES AT DIAGNOSIS ARE THE MOST IMPORTANT PROGNOSTIC FACTOR IN THE MYELODYSPLASTIC SYNDROMES (MDS), Blood, 88(10), 1996, pp. 2317-2317
Authors:
PRINCE HM
IMRIE K
KEATING A
MEHARCHAND J
STEWART AK
Citation: Hm. Prince et al., THE INFLUENCE OF PRIOR ALKYLATING AGENT THERAPY ON THE COLLECTION OF PERIPHERAL-BLOOD PROGENITOR CELLS IN MULTIPLE-MYELOMA, Experimental hematology, 23(8), 1995, pp. 755-755
Authors:
PRINCE HM
IMRIE K
KEATING A
TRIP K
GOSS PE
CRUMP M
Citation: Hm. Prince et al., PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION WITH CYCLOPHOSPHAMIDE, ADRIAMYCIN, 5-FLUROURACIL AND G-CSF - ABILITY TO SUPPORT MULTIPLE CYCLES OF HIGH-DOSE CHEMOTHERAPY, Experimental hematology, 23(8), 1995, pp. 755-755
Authors:
PRINCE HM
IMRIE K
KEATING A
GIROUARD C
STEWART AK
Citation: Hm. Prince et al., PERIPHERAL-BLOOD PROGENITOR-CELL COLLECTIONS IN MULTIPLE-MYELOMA - LIMITED VALUE OF REPEAT COLLECTIONS, Experimental hematology, 23(8), 1995, pp. 756-756
Authors:
STEWART AK
IMRIE K
PRINCE HM
ANANIA S
KEATING A
SUTHERLAND DR
Citation: Ak. Stewart et al., OPTIMIZING THE CD34(-1(+) CELL CONTENT OF PERIPHERAL-BLOOD STEM-CELL (PBSC) COLLECTIONS(), THY), Experimental hematology, 23(8), 1995, pp. 786-786
Authors:
PRINCE HM
CRUMP M
IMRIE K
STEWART K
GIROUARD C
KEATING A
Citation: Hm. Prince et al., OUTCOME AFTER HIGH-DOSE ETOPOSIDE AND MELPHALAN AND AUTOTRANSPLANT INPATIENTS FAILING FRONT-LINE CHEMOTHERAPY FOR HODGKINS-DISEASE, Experimental hematology, 23(8), 1995, pp. 858-858
Authors:
PRINCE HM
CRUMP M
IMRIE K
STEWART K
GIROUARD C
KEATING A
Citation: Hm. Prince et al., LONG-TERM DISEASE-FREE SURVIVAL AFTER INTENSIVE THERAPY AND AUTOTRANSPLANT IN PATIENTS FAILING INDUCTION CHEMOTHERAPY FOR INTERMEDIATE GRADE NON-HODGKINS-LYMPHOMA, Experimental hematology, 23(8), 1995, pp. 858-858
Authors:
STEWART AK
IMRIE K
KEATING A
ANANIA S
NAYAR R
SUTHERLAND DR
Citation: Ak. Stewart et al., OPTIMIZING THE CD34(-1(+) STEM-CELL CONTENT OF PERIPHERAL-BLOOD COLLECTIONS() AND CD34(+)THY), Experimental hematology, 23(14), 1995, pp. 1619-1627
Authors:
IMRIE K
PRINCE HM
DUBE I
CRUMP M
STEWART AK
KEATING A
Citation: K. Imrie et al., MALIGNANT KARYOTYPE PREDICTS OUTCOME AFTER BUT NOT BEFORE AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN TRANSPLANT CANDIDATES WITH ACUTEMYELOID-LEUKEMIA (AML), Blood, 86(10), 1995, pp. 157-157